SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    McIver CJ, Jacques CF, Chow SS, Munro SC, Scott GM, Roberts JA et al Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections J Clin Microbiol 2005 43 510210 doi:10.1128/JCM.43.10.5102-5110.2005.
  • 2
    Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM Congenital cytomegalovirus infection: review of the epidemiology and outcome Obstet Gynecol Surv 2002 57 24556 doi:10.1097/00006254-200204000-00024.
  • 3
    Alford CA, Stagno S, Pass RF, Britt WJ Congenital and perinatal cytomegalovirus infections Rev Infect Dis 1990 12 Suppl 7 S74553.
  • 4
    Stagno S, Whitley RJ Herpes virus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections N Engl J Med 1985 313 12704.
  • 5
    Raynor BD Cytomegalovirus infection in pregnancy Semin Perinatol 1993 17 394402.
  • 6
    Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD et al Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome JAMA 1986 256 19048 doi:10.1001/jama.256.14.1904.
  • 7
    StagnoS, RemingtonJS, KleinJO Infectious Diseases of the Fetus and Newborn Infant 2001 5th ed. Philadelphia: WB Saunders 389424.
  • 8
    Fowler KB, Stagno S, Pass RF Maternal immunity and prevention of congenital cytomegalovirus infection JAMA 2003 289 100811 doi:10.1001/jama.289.8.1008.
  • 9
    Fowler KB, Stagno S, Pass RF Interval between births and risk of congenital cytomegalovirus infection Clin Infect Dis 2004 38 10357 doi:10.1086/382533.
  • 10
    Stagno S, Britt W RemingtonJS, KleinJO, WilsonCB, BakerCJ Cytomegalovirus infections Infectious Diseases of the Fetus and Newborn Infant 2006 6th ed. Philadelphia: Elsevier Saunders 739.
  • 11
    Bodéus M, Hubinont C, Goubau P Increased risk of cytomegalovirus transmission in utero during late gestation Obstet Gynecol 1999 93 65860 doi:10.1016/S0029-7844(98)00538-9.
  • 12
    Palasanthiran P, Jones C, Garland S Cytomegalovirus Australasian Society for Infectious Diseases. Management of Perinatal Infections 2002 Sydney: Australasian Society for Infectious Diseases 1.
  • 13
    Lazzarotto T, Varani S, Gabrielli L, Spezzacatena P, Landini MP New advances in the diagnosis of congenital cytomegalovirus infection Intervirology 1999 42 3907 doi:10.1159/000053976.
  • 14
    Whitby EH, Paley MNJ, Griffiths PD Magnetic resonance imaging of the fetus The Obstetrician & Gynaecologist 2006 8 717 doi: 10.1576/toag.8.2.071.27224.
  • 15
    Guerra B, Lazzarotto T, Quarta S, Lanari M, Bovicelli L, Nicolosi A et al Prenatal diagnosis of symptomatic congenital cytomegalovirus infection Am J Obstet Gynecol 2000 183 47682 doi:10.1067/mob.2000.106347.
  • 16
    Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP Prenatal indicators of congenital cytomegalovirus infection J Pediatr 2000 137 905 doi:10.1067/mpd.2000.107110.
  • 17
    National Collaborating Centre for Women's and Children's Health. Antenatal Care. Routine Care for the Healthy Pregnant Woman 2008 London: RCOG Press.
  • 18
    National Institute for Health and Clinical Excellence. Antenatal Care Routine Care for the Healthy Pregnant Woman 2008 London: NICE NICE Clinical Guideline 62, [http://www.nice.org.uk/Guidance/CG62].
  • 19
    Fisher S, Genbacev O, Maidji E, Pereira L Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis J Virol 2000 74 680820 doi:10.1128/JVI.74.15.6808-6820.2000.
  • 20
    Centers for Disease Control and Prevention. Cytomegalovirus infection (CMV) [http://www.cdc.gov/cmv/].
  • 21
    Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M et al National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial J Pediatr 2003 143 1625 doi:10.1016/S0022-3476(03)00192-6.
  • 22
    Müller A, Eis-Hübinger AM, Brandhorst G, Heep A, Bartmann P, Franz AR Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant J Perinatol 2008 28 746 doi:10.1038/sj.jp.7211854.
  • 23
    Galli L, Novelli A, Chiappini E, Gervaso P, Cassetta MI, Fallani S et al Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants Pediatr Infect Dis J 2007 26 4513 doi:10.1097/01.inf.0000261111.90075.4d.
  • 24
    Acosta EP, Brundage RC, King JR, Sánchez PJ, Sood S, Agrawal V et al National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation Clin Pharmacol Ther 2007 81 86772 doi:10.1038/sj.clpt.6100150.
  • 25
    Meine Jansen CF, Toet MC, Rademaker CM, Ververs TF, Gerards LJ, van Loon AM Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir J Perinat Med 2005 33 3646 doi:10.1515/JPM.2005.065.
  • 26
    Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A et al Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection BJOG 2007 114 111321 doi:10.1111/j.1471-0528.2007.01308.x.
  • 27
    Brandy RC, Schleiss MR, Witte DP, Siddiqi TA, Fame PT Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease Pediatr Infect Dis J 2002 21 7967 doi:10.1097/00006454-200208000-00023.
  • 28
    Nigro G, Adler SP, La Torre R, Best AM Congenital Cytomegalovirus Collaborating Group Passive immunization during pregnancy for congenital cytomegalovirus infection N Engl J Med 2005 353 135062 doi:10.1056/NEJMoa043337.
  • 29
    Duff P Immunotherapy for congenital cytomegalovirus infection. [Comment.] N Engl J Med 2005 353 140204 doi:10.1056/NEJMe058172.
  • 30
    CSL Limited Bioplasma Division. CMV Immunoglobulin-VF. Product information. (Distributed by the Australian Red Cross Blood Service.) [http://www.csl.com.au/docs/33/828/PT36100100D.pdf].
  • 31
    Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL et al Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients N Engl J Med 1987 317 104954.
  • 32
    Ballow M Mechanisms of action of intravenous immune serum globulin therapy Pediatr Infect Dis J 1994 13 80611 doi:10.1097/00006454-199409000-00012.
  • 33
    Keller MA, Stiehm ER Passive immunity in prevention and treatment of infectious diseases Clin Microbiol Rev 2000 13 60214 doi:10.1128/CMR.13.4.602-614.2000.
  • 34
    Sawyer LA Antibodies for the prevention and treatment of viral diseases Antiviral Res 2000 47 5777 doi:10.1016/S0166-3542(00)00111-X.
  • 35
    ElliottEJ, CroninP, RoseD, ZurynskiY Australian Paediatric Surveillance Unit Surveillance Report, 2002–2003 2006 Sydney, Australia: Australian Paediatric Surveillance Unit 2425[http://www.apsu.org.au/index.cfm?objectid=B4CB239F-ADD1-10C3-79C6805E12285DA0].